Cover Image
市場調查報告書

冠狀動脈疾病 (CAD):全球臨床實驗檢討

Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2017

出版商 GlobalData 商品編碼 240579
出版日期 內容資訊 英文 1479 Pages
訂單完成後即時交付
價格
Back to Top
冠狀動脈疾病 (CAD):全球臨床實驗檢討 Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2017
出版日期: 2017年07月19日 內容資訊: 英文 1479 Pages
簡介

本報告提供全球冠狀動脈疾病 (CAD)治療藥物臨床實驗相關調查,不同地區的臨床實驗數資料,實驗階段,實驗狀況,採用主題及各類型贊助企業的臨床實驗資料,中斷(暫時停止,廢止,停止)的實驗清單等資料,為您概述為以下內容。

目錄

  • 表格一覽
  • 圖表一覽
  • 簡介
  • 冠狀動脈疾病 (CAD)
  • 報告指南
  • 臨床實驗 , 各地區
  • 臨床實驗 , 各國
  • - 亞太地區對臨床實驗有所貢獻的主要5個國家
  • - 歐洲對臨床實驗有所貢獻的主要5個國家
  • 對臨床實驗有所貢獻的主要國家 - 北美
  • - 中東及非洲對臨床實驗有所貢獻的主要5個國家
  • - 中南美對臨床實驗有所貢獻的主要5個國家
  • 臨床實驗 金磚四國 各國
  • 臨床實驗 G7 各國
  • 臨床實驗 - G7 各國 , 各臨床實驗狀態
  • 臨床實驗 E7 各國
  • 臨床實驗 - E7 各國 , 各臨床實驗狀態
  • 各階段臨床實驗
  • 進行中的臨床實驗 各階段
  • 臨床實驗 , 各臨床實驗狀態
  • 未完成的臨床實驗; 冠狀動脈疾病 (CAD)
  • 每段時期的實驗人數
  • 有力的贊助商
  • 參加主要企業 - 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗
  • 潛力治療藥物比較
  • 臨床實驗簡介
  • 臨床實驗概要; 主要企業
  • Abbott Laboratories
  • 臨床實驗概要; Abbott Laboratories
  • Boston Scientific Corporation
  • 臨床實驗概要; Boston Scientific Corporation
  • Cordis Corporation
  • 臨床實驗概要; Cordis Corporation
  • Medtronic, Inc.
  • 臨床實驗概要; Medtronic, Inc.
  • Johnson & Johnson
  • 臨床實驗概要; Johnson & Johnson
  • AstraZeneca PLC
  • 臨床實驗概要; AstraZeneca PLC
  • GE Healthcare
  • 臨床實驗概要; GE Healthcare
  • Pfizer Inc.
  • 臨床實驗概要; Pfizer Inc.
  • Gilead Sciences, Inc.
  • 臨床實驗概要; Gilead Sciences, Inc.
  • Eli Lilly and Company
  • 臨床實驗概要; Eli Lilly and Company
  • POINT Biomedical Corporation
  • 臨床實驗概要; POINT Biomedical Corporation
  • Sahajanand Medical Technologies Pvt. Ltd.
  • 臨床實驗概要; Sahajanand Medical Technologies Pvt. Ltd.
  • Lantheus Medical Imaging, Inc.
  • 臨床實驗概要; Lantheus Medical Imaging, Inc.
  • Astellas
  • 臨床實驗概要; Astellas
  • Cook
  • 臨床實驗概要; Cook
  • Bracco Diagnostics, Inc.
  • 臨床實驗概要; Bracco Diagnostics, Inc.
  • Sanofi
  • 臨床實驗概要; Sanofi
  • Intermountain Healthcare, Inc.
  • 臨床實驗概要; Intermountain Healthcare, Inc.
  • Forest Laboratories, Inc.
  • 臨床實驗概要; Forest Laboratories, Inc.
  • 小野藥品工業
  • 臨床實驗概要; 小野藥品工業
  • 臨床實驗概要; 最高級大學 / 研究機關 / 醫院
  • Seoul National University Hospital
  • 臨床實驗概要; Seoul National University Hospital
  • Sapienza University of Rome
  • 臨床實驗概要; Sapienza University of Rome
  • University of Ottawa Heart Institute
  • 臨床實驗概要; University of Ottawa Heart Institute
  • Yonsei University
  • 臨床實驗概要; Yonsei University
  • 熊本大學
  • 臨床實驗概要; 熊本大學
  • Emory University
  • 臨床實驗概要; Emory University
  • University Hospital Inselspital, Berne
  • 臨床實驗概要; University Hospital Inselspital, Berne
  • Norwegian University of Science and Technology
  • 臨床實驗概要; Norwegian University of Science and Technology
  • National Taiwan University Hospital
  • 臨床實驗概要; National Taiwan University Hospital
  • MedStar Health Research Institute
  • 臨床實驗概要; MedStar Health Research Institute
  • 京都大學
  • 臨床實驗概要; 京都大學
  • Samsung Medical Center
  • 臨床實驗概要; Samsung Medical Center
  • University of Sao Paulo
  • 臨床實驗概要; University of Sao Paulo
  • Deutsches Herzzentrum Munchen
  • 臨床實驗概要; Deutsches Herzzentrum Munchen
  • Mayo Clinic
  • 臨床實驗概要; Mayo Clinic
  • Oslo University Hospital
  • 臨床實驗概要; Oslo University Hospital
  • University of Leipzig
  • 臨床實驗概要; University of Leipzig
  • Massachusetts General Hospital
  • 臨床實驗概要; Massachusetts General Hospital
  • Skejby Hospital
  • 臨床實驗概要; Skejby Hospital
  • Montreal Heart Institute Research Centre
  • 臨床實驗概要; Montreal Heart Institute Research Centre
  • Five 主要 臨床簡介

附錄

  • 簡稱
  • 定義
  • 調查方法
  • 二級研究
  • About GlobalData
  • 諮詢方式
  • 免責聲明
  • 資訊來源

表格一覽

表格一覽

  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 臨床實驗 各地區
  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 臨床實驗 , 各國排名
  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 進行中的臨床實驗 , 各國排名
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 亞太地區, 主要5個國家
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 歐洲, 主要5個國家
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 北美, 主要國家
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 中東及非洲, 主要5個國家
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 中南美, 主要5個國家
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 金磚四國 各國
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, G7 各國
  • 冠狀動脈疾病 (CAD) 治療藥物市場, G7 各國, 臨床實驗 , 各臨床實驗狀態
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, E7 各國
  • 冠狀動脈疾病 (CAD) 治療藥物市場, E7 各國, 臨床實驗 , 各臨床實驗狀態
  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 各階段臨床實驗
  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 進行中的臨床實驗 各階段
  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 臨床實驗 , 各臨床實驗狀態
  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 暫時停止的臨床實驗
  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 中止的臨床實驗
  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 終止的臨床實驗
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 全球市場、 平均登計對象人數趨勢
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 全球市場、 主要的贊助商
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 全球市場、 主要企業 各階段
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 全球市場、 臨床實驗, 各有潛力治療藥
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Abbott Laboratories
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Boston Scientific Corporation
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Cordis Corporation
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Medtronic, Inc.
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Johnson & Johnson
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- AstraZeneca PLC
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- GE Healthcare
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Pfizer Inc.
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Gilead Sciences, Inc.
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Eli Lilly and Company
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- POINT Biomedical Corporation
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Sahajanand Medical Technologies Pvt. Ltd.
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Lantheus Medical Imaging, Inc.
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Astellas
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Cook
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Bracco Diagnostics, Inc.
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Sanofi
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Intermountain Healthcare, Inc.
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Forest Laboratories, Inc.
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- 小野藥品工業
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Seoul National University Hospital
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Sapienza University of Rome
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- University of Ottawa Heart Institute
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Yonsei University
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- 熊本大學
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Emory University
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- University Hospital Inselspital, Berne
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Norwegian University of Science and Technology
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- National Taiwan University Hospital
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- MedStar Health Research Institute
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- 京都大學
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Samsung Medical Center
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- University of Sao Paulo
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Deutsches Herzzentrum Munchen
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Mayo Clinic
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Oslo University Hospital
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- University of Leipzig
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Massachusetts General Hospital
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Skejby Hospital
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗 Market, 全球市場、 臨床實驗- Montreal Heart Institute Research Centre

圖表一覽

圖表一覽

  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 臨床實驗 各地區 (%)
  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 臨床實驗 , 各國排名
  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 進行中的臨床實驗 , 各國排名
  • (%)冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 亞太地區, 主要5個國家
  • (%)冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 歐洲, 主要5個國家
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 北美, 主要國家 (%)
  • (%)冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 中東及非洲, 主要5個國家
  • (%)冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 中南美, 主要5個國家
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 金磚四國 各國 (%)
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, G7 各國 (%)
  • 冠狀動脈疾病 (CAD) 治療藥物市場, G7 各國, 臨床實驗 , 各臨床實驗狀態
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, E7 各國 (%)
  • 冠狀動脈疾病 (CAD) 治療藥物市場, E7 各國, 臨床實驗 , 各臨床實驗狀態
  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 各階段臨床實驗 (%)
  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 進行中的臨床實驗 各階段
  • 冠狀動脈疾病 (CAD) 治療藥物市場, 全球市場、 臨床實驗 , 各臨床實驗狀態
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 全球市場、 平均登計對象人數趨勢
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 全球市場、 主要的贊助商
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 全球市場、 主要企業 各階段
  • 冠狀動脈疾病 (CAD) 治療藥物的臨床實驗, 全球市場、 臨床實驗, 各有潛力治療藥
  • GlobalData 調查方法

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC4339CTIDB

GlobalData's clinical trial report, "Coronary Artery Disease (CAD) (Ischemic Heart Disease) Global Clinical Trials Review, H2, 2017" provides an overview of Coronary Artery Disease (CAD) (Ischemic Heart Disease) clinical trials scenario. This report provides top line data relating to the clinical trials on Coronary Artery Disease (CAD) (Ischemic Heart Disease). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 4
  • List of Figures 5
  • Report Guidance 6
  • GlobalData Clinical Trials Report Coverage 7
  • Clinical Trials by Region 8
  • Clinical Trials and Average Enrollment by Country 9
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
  • Top Five Countries Contributing to Clinical Trials in Europe 13
  • Top Countries Contributing to Clinical Trials in North America 14
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa 15
  • Top Five Countries Contributing to Clinical Trials in Central and South America 16
  • Clinical Trials by G7 Countries: Proportion of Coronary Artery Disease (CAD) (Ischemic Heart Disease) to Cardiovascular Clinical Trials 17
  • Clinical Trials by Phase in G7 Countries 19
  • Clinical Trials in G7 Countries by Trial Status 20
  • Clinical Trials by E7 Countries: Proportion of Coronary Artery Disease (CAD) (Ischemic Heart Disease) to Cardiovascular Clinical Trials 22
  • Clinical Trials by Phase in E7 Countries 24
  • Clinical Trials in E7 Countries by Trial Status 25
  • Clinical Trials by Phase 27
  • In Progress Trials by Phase 28
  • Clinical Trials by Trial Status 29
  • Clinical Trials by End Point Status 31
  • Subjects Recruited Over a Period of Time 32
  • Clinical Trials by Sponsor Type 33
  • Prominent Sponsors 34
  • Top Companies Participating in Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials 36
  • Prominent Drugs 38
  • Latest Clinical Trials News on Coronary Artery Disease (CAD) (Ischemic Heart Disease) 40
  • Jun 28, 2017: Resverlogix Announces Fourth Positive Recommendation From Data Safety Monitoring Board For Phase 3 Study of Apabetalone 40
  • Jun 27, 2017: Merck Provides Update on REVEAL Outcomes Study of Anacetrapib 40
  • Clinical Trial Profile Snapshots 41

Appendix 1477

  • Abbreviations 1477
  • Definitions 1477
  • Research Methodology 1478
  • Secondary Research 1478
  • About GlobalData 1479
  • Contact Us 1479
  • Source 1479

List of Tables

List of Tables

  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials by Region, 2017* 8
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 10
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 12
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 13
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, North America, Top Countries, 2017* 14
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 15
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 16
  • Proportion of Coronary Artery Disease (CAD) (Ischemic Heart Disease) to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 18
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 19
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 21
  • Proportion of Coronary Artery Disease (CAD) (Ischemic Heart Disease) to Cardiovascular Clinical Trials, E7 Countries (%), 2017* 23
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 24
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 26
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials by Phase, 2017* 27
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 28
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 30
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 31
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 32
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 33
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 35
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 37
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 39

List of Figures

List of Figures

  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials by Region (%), 2017* 8
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 11
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 12
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 13
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 14
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 15
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 16
  • Proportion of Coronary Artery Disease (CAD) (Ischemic Heart Disease) to Cardiovascular Clinical Trials, G7 Countries (%), 2017* 17
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 19
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 20
  • Proportion of Coronary Artery Disease (CAD) (Ischemic Heart Disease) to Cardiovascular Clinical Trials, E7 Countries (%), 2017* 22
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 24
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 25
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials by Phase (%), 2017* 27
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 28
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 29
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 31
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 32
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 33
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 34
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 36
  • Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 38
  • GlobalData Methodology 1478
Back to Top